Announcements Trials
Browse Landscape

Status

Completed 4Not yet recruiting 3Unknown 2Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasms, Second Primary 1Neoplasms 1Congenital Abnormalities 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Blood Specimen Collection 121Surveys and Questionnaires 82Observation 50Radiotherapy 40Drug Therapy 35Surgical Procedures, Operative 34Biopsy 31Specimen Handling 28Data Collection 27Watchful Waiting 21Interviews as Topic 20Immune Checkpoint Inhibitors 19Magnetic Resonance Imaging 18Liquid Biopsy 16Magnetic Resonance Spectroscopy 15Immunotherapy 15Standard of Care 13pembrolizumab 12Tomography, X-Ray Computed 12Ultrasonography 11trastuzumab deruxtecan 10lenvatinib 10Radiosurgery 10Nivolumab 10Carboplatin 10Tissue Banks 9Restraint, Physical 9Radiation 9Neoadjuvant Therapy 9Endoscopy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Observational × Tyrosine Kinase Inhibitors × Clear all
NCT03958565 2026-06-03

Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.

University of Colorado, Denver

Recruiting
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04151342 2025-12-03

CARMA-BROS

University Health Network, Toronto

Recruiting
5,500 enrolled

Congenital Abnormalities, Neoplasms, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡